about
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...
Read More
2.48
-0.01
(-0.40%)
102.9K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..